Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer

Fig. 5

The oncogenic function of CCNA2 in LUAD cells. (A) 27 paired NSCLC and normal tissue was detected by qRT-PCR. (B) CCNA2 was knocked down in A549 cells via siRNA transfection. (C) CCNA2 knockdown inhibited A549 cell proliferation by CCK-8 assay. (D) CCNA2 silencing decreased A549 cell migration ability. (E) CCNA2 knockdown impaired A549 cell invasion. (F) CCNA2 silencing increased A549 cell apoptosis demonstrated by flow cytometry analysis. * P < 0.05; ** P < 0.01; *** P < 0.001

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us